Hematologic agents Flashcards

1
Q

Bone marrow production

A

produces billions of cells each day, marrow must produce enough cells to maintain a stable cell # per body mass as infant grows. Prematurity —- anemia and neutropenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is erythropoietin?

A

endogenous glycoprotein that regulates RBC production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Serum EPO concentrations at birth

A

decrease following birth to reach nadir at 4-6 weeks. By 10-12 months they reach adult levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Serum EPO concentrations in preterm

A

fall of EPO is more profound and persists longer contributing to anemia of prematurity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Does EPO cross the placenta

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Production of EPO is stimulated and regulated by

A

Stimulated by hypoxia inducible factors 1 and 2 and regulated by requirement of tissue oxygenation BODY SENSES IT NEEDS MORE OXYGEN SO EPO STIMULATED TO MAKE MORE RBC’s TO CARRY OXYGEN TO BODY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does EPO maintain RBC production

A

inhibiting apoptosis of erythroid progenitors and stimulating their proliferation and differentiation into normoblasts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Recombinant EPO indications

A

used to treat or prevent anemia due to renal failure and prematurity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anemia of prematurity clinical trail

A

suggests combination of iron supplementation and rEPO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hyporegenerative anemia of neonates with Rh-hemolytic disease clinical trial

A

mixed results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anemia of BPD clinical trial

A

Infants received 200 U of rEPO per day for 10 days and showed increased retics, hct, fewer transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CHD clinical trial

A

Neonates awaiting transplant received 200 U per day and had significant increase in hct and decrease in transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What must be given concurrently with rEPO

A

Iron 6-8 mg/kg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Recommended doses of rEPO

A

SQ 400 U/kg 3 times per week for 2 wks

IV 200 U/kg every day for 2 wks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aranesp

A

Erythropoiesis stimulating protein, single once a week injection but very few studies done

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adverse effects of rEPO

A

several in adults, none in neonatal studies

17
Q

rEPO and ROP

A

Early high doses may have protective effect on retina in 1st stage of ROP
one study suggested increased risk of ROP when started on early high does rEPO with iron

18
Q

Side effect of rEPO

A

potential effect on iron balance

Beneficial side effects: inc erythropoiesis and megaryocytopoiesis.

19
Q

Fe and the neonate

A

increase risk for deficiency bc bulk of Fe transfer occurs in 3rd trimester.

20
Q

Fe

A

Mineral required for transfer of oxygen from lungs to tissues and storage of oxygen for use during muscle contx.
Essential for normal growth/development
important component for proteins and enzymes required for oxygen transport, cell division, neural transmitter synthesis, myelination and cellular oxidative metabolism

21
Q

Excessive Fe intake

A

common cause of poisoning death in less than 6 yrs of age in US

22
Q

Supplementation

A

Important! BUT NOT BEFORE 2 WEEKS!

Endogenous stores depleted by 6 months
Breastfed: 1 mg/kg/day starting 4-6 months
Preterm: 2 mg/kg/day starting 2-4 weeks till 12 months

23
Q

G-CSF

A

granulocyte colony stimulating factor: physiologic regulator of neutrophil production and function

24
Q

rG-CSF has an effect on what?

A

white cell maturation and function
Enhancement of neutrophils functions:
chemotaxis, phagocytosis, superoxide production, bactericidal activity

25
Q

rG-CSF and bacterial sepsis trial

A

Does appear to increase circulating neutrophil counts but unclear whether there is clinical benefit. No significant side effects reported

26
Q

rG-CSF and PIH trials

A

suggests that it could be useful

27
Q

rG-CSF and alloimmune neutropenia trials

A

Good results when given and response evident in 24-48 hours

28
Q

rG-CSF and autoimmune neutropenia trials

A

good results when given

29
Q

rG-CSF and chronic idiopathic neutropenia

A

Can respond but usually remits after 3-6 months so tx may not be necessary

30
Q

Adverse effects of rG-CSF rare and include:

A

thromobocytopenia, osteoporosis

CONTRAINDICATED WITH HYPERSENSITIVITY TO E-COLI DERIVED PROTEINS

31
Q

What is rGM-CSF

A

Recombinant granulocyte- macrophage colony stimulating factor: increases neutrophil counts and may decrease mortality due to sepsis.
Significant increase in ANC with 48 hours